Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer.
作者信息
Zhong Weilong, Sun Tao
机构信息
Department of Gastroenterology and Hepatology, General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin Medical University, Tianjin, China.
State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
出版信息
Front Oncol. 2023 Jan 25;13:1121416. doi: 10.3389/fonc.2023.1121416. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer.社论：上皮-间质转化（EMT）作为癌症的治疗靶点
Front Oncol. 2023 Jan 25;13:1121416. doi: 10.3389/fonc.2023.1121416. eCollection 2023.
2
Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.中医药防治肝癌的研究进展：上皮-间质转化。
J Integr Med. 2021 Nov;19(6):469-477. doi: 10.1016/j.joim.2021.08.004. Epub 2021 Aug 25.
3
Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression.
J Cell Biochem. 2019 Feb;120(2):1068-1079. doi: 10.1002/jcb.27588. Epub 2018 Nov 15.
4
Traditional Chinese Medicine and regulatory roles on epithelial-mesenchymal transitions.中医及其在上皮-间质转化中的调控作用
Chin Med. 2019 Sep 23;14:34. doi: 10.1186/s13020-019-0257-6. eCollection 2019.
5
Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms.中药作为结直肠癌上皮-间质转化诱导转移的有效逆转剂：分子靶点与机制
Front Pharmacol. 2022 Mar 4;13:842295. doi: 10.3389/fphar.2022.842295. eCollection 2022.
6
The mechanism of action of Fangji Huangqi Decoction on epithelial-mesenchymal transition in breast cancer using high-throughput next-generation sequencing and network pharmacology.基于高通量下一代测序和网络药理学研究防己黄芪汤调控乳腺癌上皮间质转化的作用机制。
J Ethnopharmacol. 2022 Feb 10;284:114793. doi: 10.1016/j.jep.2021.114793. Epub 2021 Oct 30.
7
Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.结直肠癌中上皮-间质转化的药物靶点。
Curr Pharm Des. 2022;28(28):2298-2311. doi: 10.2174/1381612828666220728152350.
8
Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.更深入地了解 SIRT1 在癌症中的作用：控制癌细胞上皮-间充质转化的潜在治疗靶点。
J Cell Physiol. 2018 Jun;233(6):4443-4457. doi: 10.1002/jcp.26302. Epub 2018 Jan 15.
9
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.甲磺酸艾日布林通过使上皮-间质转化（EMT）状态向间质-上皮转化（MET）状态逆转，抑制乳腺癌细胞的实验性转移。
Br J Cancer. 2014 Mar 18;110(6):1497-505. doi: 10.1038/bjc.2014.80. Epub 2014 Feb 25.
10
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.混合上皮/间充质表型促进多种癌的转移和治疗抵抗。
Pharmacol Ther. 2019 Feb;194:161-184. doi: 10.1016/j.pharmthera.2018.09.007. Epub 2018 Sep 28.
引用本文的文献
1
Investigating Anti-Breast Cancer Properties of the Antibiotic Vancomycin-A Drug Repurposing study using Molecular Docking Techniques.利用分子对接技术研究抗生素万古霉素的抗乳腺癌特性——一项药物重新利用研究
IOSR J Dent Med Sci. 2025 Jun;24(6):04-9. doi: 10.9790/0853-2406020409.
2
Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease.基质金属蛋白酶驱动的上皮-间质转化：对健康与疾病的影响
J Transl Med. 2025 Apr 11;23(1):436. doi: 10.1186/s12967-025-06447-w.
3
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.哺乳动物癌症干细胞耐药性的综合综述：对癌症治疗的启示
Cancer Cell Int. 2024 Dec 18;24(1):406. doi: 10.1186/s12935-024-03558-0.
4
Macrophage Migration Inhibitory Factor (MIF) Upregulates CXCR7 and Contributes to Chemotherapy Resistance in Colorectal Cancer.巨噬细胞移动抑制因子（MIF）上调 CXCR7 并促进结直肠癌的化疗耐药性。
Cell Biochem Biophys. 2024 Dec;82(4):3437-3452. doi: 10.1007/s12013-024-01430-6. Epub 2024 Jul 17.
5
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.揭示卵巢肿瘤的免疫原性作为治疗成功的关键催化剂。
Cancers (Basel). 2023 Dec 2;15(23):5694. doi: 10.3390/cancers15235694.
6
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II.社论：上皮-间质转化（EMT）作为癌症的治疗靶点，第二卷。
Front Oncol. 2023 Jun 20;13:1218855. doi: 10.3389/fonc.2023.1218855. eCollection 2023.
7
Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis.上皮-间充质可塑性的治疗靶向方法以对抗癌症转移。
Med Oncol. 2023 May 29;40(7):190. doi: 10.1007/s12032-023-02049-y.
本文引用的文献
1
EMT-associated microRNAs and their roles in cancer stemness and drug resistance.EMT 相关 microRNAs 及其在癌症干性和耐药性中的作用。
Cancer Commun (Lond). 2021 Mar;41(3):199-217. doi: 10.1002/cac2.12138. Epub 2021 Jan 27.
2
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
3
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.上皮-间质转化、癌症干细胞与耐药性：机制联系及临床意义
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629. doi: 10.1038/nrclinonc.2017.44. Epub 2017 Apr 11.
4
EMT and tumor metastasis.上皮-间质转化与肿瘤转移
Clin Transl Med. 2015 Feb 26;4:6. doi: 10.1186/s40169-015-0048-3. eCollection 2015.
5
EMT as the ultimate survival mechanism of cancer cells.癌细胞的终极生存机制 EMT。
Semin Cancer Biol. 2012 Jun;22(3):194-207. doi: 10.1016/j.semcancer.2012.02.013. Epub 2012 Mar 8.
Zotero 插件